Cargando…
Dasatinib-Induced Pleural and Pericardial Effusions
Chronic myeloid leukemia (CML) is a myeloproliferative disease associated with the Philadelphia chromosome and BCR-ABL1 fusion gene. Tyrosine kinase inhibitors (TKI) are now the standard therapy for this condition. Among the approved TKIs for CML is dasatinib. We present a case of a 58-year-old Egyp...
Autores principales: | Hailan, Yousef M, Elyas, Ahmed, Abdulla, Mohammad A, Yassin, Mohamed A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611763/ https://www.ncbi.nlm.nih.gov/pubmed/34824936 http://dx.doi.org/10.7759/cureus.19024 |
Ejemplares similares
-
Dasatinib induced pleural effusions - Reply
por: AJ Abdulla, Mohammad, et al.
Publicado: (2020) -
A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion
por: Elkholy, Karim O, et al.
Publicado: (2020) -
Dasatinib induced pleuro-pericardial effusion
por: Mishra, Ajay Kumar, et al.
Publicado: (2020) -
Pleural and Pericardial Effusion With COVID-19 and Systemic Lupus Erythematosus and Its Recurrence: A Case Study
por: Yost, Connor, et al.
Publicado: (2023) -
Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)